KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Equity (2018 - 2026)

Castle Biosciences' Return on Equity history spans 8 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2025 for Castle Biosciences, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for CSTL hit a ceiling of 0.0% in Q4 2024 and a floor of 0.0% in Q2 2023.
  • Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
  • The widest YoY moves for Return on Equity: up 0bps in 2021, down 0bps in 2021.
  • Tracing CSTL's Return on Equity over 5 years: stood at 0.0% in 2021, then tumbled by -78bps to 0.0% in 2022, then increased by 11bps to 0.0% in 2023, then surged by 128bps to 0.0% in 2024, then tumbled by -227bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for CSTL at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.